MyAverix Finance
SHE · Healthcare
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258)
Biotechnology
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.92B, P/E ratio is 37.86, net margin is 17.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301258
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — FAQ
What is Suzhou Fushilai Pharmaceutical Co. Ltd.'s market cap?
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a reported market cap of $2.92B (data as of 2026-03-29).
What is 301258's P/E ratio?
The price-to-earnings (P/E) ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) is 37.86 (data as of 2026-03-29).
Does Suzhou Fushilai Pharmaceutical Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Suzhou Fushilai Pharmaceutical Co. Ltd. (301258). Check the MyAverix Finance app for the latest dividend data.
What sector is Suzhou Fushilai Pharmaceutical Co. Ltd. in?
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 301258 listed on?
301258 is listed on SHE.
What is Suzhou Fushilai Pharmaceutical Co. Ltd.'s net margin?
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) reports a net margin of 17.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.